The unappreciated importance of blood pressure in recent and older atrial fibrillation trials
- 1 November 2013
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Hypertension
- Vol. 31 (11), 2109-2117
- https://doi.org/10.1097/hjh.0b013e3283638194
Abstract
Atrial fibrillation and arterial hypertension represent two common clinical conditions that frequently coexist, especially in older individuals, and are associated with increased risk of stroke. Antihypertensive therapy reduces the risk of stroke by approximately 40%. It has been observed that stroke rates were reduced by 10% for every 2-mmHg reduction of blood pressure. Antithrombotic therapy reduces significantly the risk for ischemic stroke in patients with atrial fibrillation at the expense of increased risk of intracranial bleeding. The importance of hypertension in patients with atrial fibrillation is recognized by its inclusion both in the CHA2DS2-VASc (risk for stroke) and the HAS-BLED (Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile international normalized ratio, Elderly, Drugs/alcohol concomitantly) scores (risk for bleeding) and the presence of hypertension alone is an indication to initiate antithrombotic treatment. However, blood pressure remains remarkably unappreciated in previous and recent atrial fibrillation trials. Very limited, if any, data are provided regarding blood pressure, including in-study and final blood pressure levels, blood pressure control, and concomitant antihypertensive medication. In contrast, several lines of evidence point toward a significant role of pre and in-treatment blood pressure for ischemic and hemorrhagic stroke in patients with atrial fibrillation as well as for the incidence of intracranial bleeding during antithrombotic treatment. We propose that regular blood pressure recording should be mandatory in all future studies with antithrombotic therapy, analyses based on final and in-study blood pressure values, hypertension control, and antihypertensive medication should be performed, and the outcome be adjusted for blood pressure-related variables.This publication has 65 references indexed in Scilit:
- Effects of Blood Pressure Lowering on Intracranial and Extracranial Bleeding in Patients on Antithrombotic TherapyStroke, 2012
- Antithrombotic Therapy for Atrial Fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2012
- Pharmacotherapy for the Secondary Prevention of StrokeDrugs, 2009
- Using Public Health Indicators to Measure the Success of Hypertension ControlHypertension, 2007
- Differences in Blood Pressure Control and Stroke Mortality Across SpainHypertension, 2007
- Use and Effectiveness of Warfarin in Medicare Beneficiaries With Atrial FibrillationStroke, 2006
- Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic AttackStroke, 2005
- Avoiding Central Nervous System Bleeding During Antithrombotic TherapyStroke, 2005
- The statin warsThe Lancet, 2003
- Factors Associated With Ischemic Stroke During Aspirin Therapy in Atrial FibrillationStroke, 1999